Search Results - Habra, Mouhammed
- Showing 1 - 20 results of 51
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature by Economides, Minas P., Shah, Amishi Y., Jimenez, Camilo, Habra, Mouhammed A., Desai, Monica, Campbell, Matthew T.
Published 2020Text -
9
-
10
Imaging characteristics of pathologically proven adrenal adenomas with myelolipomatous degeneration: correlation with clinical and pathologic features by Guccione, Jeffrey, Soliman, Moataz, Zhang, Miao, Habra, Mouhammed Amir, Collins, Katrina, Zhao, Jianping, Elsayes, Khaled M
Published 2022Text -
11
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW ON THE EVALUATION AND MANAGEMENT OF ADRENOCORTICAL CARCINOMA IN AN ADULT: A PRACTICAL APPROACH by Kiseljak-Vassiliades, Katja, Bancos, Irina, Hamrahian, Amir, Habra, Mouhammed Amir, Vaidya, Anand, Levine, Alice C., Else, Tobias
Published 2020Text -
12
[(18)F]Fluorodeoxyglucose Positron Emission Tomography–Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case by Chuang, Hubert H., Deniz, Ferhat, Sircar, Kanishka, Jimenez, Camilo, Rubin De Celis, Carlos, Wood, Christopher G., Habra, Mouhammed Amir
Published 2012Text -
13
Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? by Jimenez, Camilo, Armaiz-Pena, Gustavo, Dahia, Patricia L. M., Lu, Yang, Toledo, Rodrigo A., Varghese, Jeena, Habra, Mouhammed Amir
Published 2022Text -
14
Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical... by Habra, Mouhammed Amir, Hammer, Gary D, Kebebew, Electron, Worden, Francis P, Raj, Nitya, Hallanger-Johnson, Julie E, Grauer, Andreas, Moraitis, Andreas
Published 2021Text -
15
-
16
The Clinical Impact of [(68)Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone – Secreting Tumors by Wannachalee, Taweesak, Turcu, Adina F., Bancos, Irina, Habra, Mouhammed Amir, Avram, Anca M., Chuang, Hubert H., Waguespack, Steven G., Auchus, Richard J.
Published 2019Text -
17
SAT-175 Trial in Progress Interim Report: A Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma by Bedrose, Sara Shokry Daniel, Altameemi, Lina, Daher, Marilyne, De Rosa, Gina Tamsen, Varghese, Jeena Mary, Jimenez, Camilo, Campbell, Matthew, Habra, Mouhammed Amir
Published 2020Text -
18
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study by Kimpel, Otilia, Bedrose, Sara, Megerle, Felix, Berruti, Alfredo, Terzolo, Massimo, Kroiss, Matthias, Mai, Knut, Dekkers, Olaf M., Habra, Mouhammed Amir, Fassnacht, Martin
Published 2021Text -
19
Clinical Benefits of Systemic Chemotherapy for Patients with Metastatic Pheochromocytomas or Sympathetic Extra-Adrenal Paragangliomas: Insights from the Largest Single Institutiona... by Ayala-Ramirez, Montserrat, Feng, Lei, Habra, Mouhammed A., Rich, Thereasa, Dickson, Paxton V., Perrier, Nancy, Phan, Alexandria, Waguespack, Steven, Patel, Shreyaskumar, Jimenez, Camilo
Published 2011Text -
20
Bone Metastases and Skeletal-Related Events in Patients With Malignant Pheochromocytoma and Sympathetic Paraganglioma by Ayala-Ramirez, Montserrat, Palmer, J. Lynn, Hofmann, Marie-Claude, de la Cruz, Maxine, Moon, Bryan S., Waguespack, Steven G., Habra, Mouhammed Amir, Jimenez, Camilo
Published 2013Text